Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Human Immunodeficiency Virus | Research

Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe

Authors: Morten Skovdal, Phyllis Magoge-Mandizvidza, Freedom Dzamatira, Rufurwokuda Maswera, Constance Nyamukapa, Ranjeeta Thomas, Owen Mugurungi, Simon Gregson

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

In sub-Saharan Africa, adolescent girls and young women (AGYW) are at high risk of acquiring HIV. A growing number of sub-Saharan African countries are beginning to avail pre-exposure prophylaxis, or PrEP, but with limited success. Unpacking strategies to overcome barriers to the uptake of PrEP is critical to prevent HIV amongst AGYW. This article explores health professionals’ views and recommendations on what is required to increase uptake of PrEP.

Methods

The study draws on interview data from 12 providers of HIV prevention services in eastern Zimbabwe. The healthcare providers were purposefully recruited from a mix of rural and urban health facilities offering PrEP. The interviews were transcribed and imported into NVivo 12 for thematic coding and network analysis.

Results

Our analysis revealed six broad strategies and 15 concrete recommendations which detail the range of elements healthcare providers consider central for facilitating engagement with PrEP. The healthcare providers called for: (1) PrEP marketing campaigns; (2) youth-friendly services or corners; (3) improved PrEP delivery mechanisms; (4) improvements in PrEP treatment; (5) greater engagement with key stakeholders, including with young people themselves; and (6) elimination of costs associated with PrEP use. These recommendations exemplify an awareness amongst healthcare providers that PrEP access is contingent on a range of factors both inside and outside of the clinical setting.

Conclusions

Healthcare providers are at the frontline of the HIV epidemic response. Their community-embeddedness, coupled with their interactions and encounters with AGYW, make them well positioned to articulate context-specific measures for improving access to PrEP. Importantly, the breadth of their recommendations suggests recognition of PrEP use as a complex social practice that requires integration of a combination of interventions, spanning biomedical, structural, and behavioural domains.
Appendix
Available only for authorised users
Literature
1.
go back to reference UNAIDS. UNAIDS Data 2018. Geneva: UNAIDS; 2018. UNAIDS. UNAIDS Data 2018. Geneva: UNAIDS; 2018.
2.
go back to reference UNAIDS. Confronting Inequalities: Lessons for pandemic responses from 40 years of AIDS. Geneva: UNAIDS; 2021. UNAIDS. Confronting Inequalities: Lessons for pandemic responses from 40 years of AIDS. Geneva: UNAIDS; 2021.
3.
go back to reference UNAIDS. Global AIDS update 2019—Communities at the centre. Geneva: Joint United Nations Programme on HIV/AIDS; 2019. UNAIDS. Global AIDS update 2019—Communities at the centre. Geneva: Joint United Nations Programme on HIV/AIDS; 2019.
4.
go back to reference McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet. 2016;387(10013):53–60.CrossRef McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet. 2016;387(10013):53–60.CrossRef
5.
go back to reference WHO. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). In. Geneva: World Health Organization; 2015. WHO. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). In. Geneva: World Health Organization; 2015.
6.
go back to reference Auerbach JD, Hoppe TA. Beyond “getting drugs into bodies”: social science perspectives on pre-exposure prophylaxis for HIV. J Int AIDS Soc. 2015;18:19983.CrossRef Auerbach JD, Hoppe TA. Beyond “getting drugs into bodies”: social science perspectives on pre-exposure prophylaxis for HIV. J Int AIDS Soc. 2015;18:19983.CrossRef
7.
go back to reference Cluver LD, Orkin MF, Yakubovich AR, Sherr L. Combination social protection for reducing HIV-risk behavior amongst adolescents in South Africa. J Acquir Immune Defic Syndr. 2016;72(1):96.CrossRef Cluver LD, Orkin MF, Yakubovich AR, Sherr L. Combination social protection for reducing HIV-risk behavior amongst adolescents in South Africa. J Acquir Immune Defic Syndr. 2016;72(1):96.CrossRef
8.
go back to reference Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, Van Der Straten A, Noguchi L. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.CrossRef Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, Van Der Straten A, Noguchi L. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.CrossRef
9.
go back to reference Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.CrossRef Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.CrossRef
10.
go back to reference Celum CL, Delany‐Moretlwe S, Baeten JM, Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019; 22(S4). Celum CL, Delany‐Moretlwe S, Baeten JM, Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019; 22(S4).
11.
go back to reference Jackson-Gibson M, Ezema AU, Orero W, Were I, Ohiomoba RO, Mbullo PO, Hirschhorn LR. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21(1):1284.CrossRef Jackson-Gibson M, Ezema AU, Orero W, Were I, Ohiomoba RO, Mbullo PO, Hirschhorn LR. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21(1):1284.CrossRef
12.
go back to reference Gombe MM, Cakouros BE, Ncube G, Zwangobani N, Mareke P, Mkwamba A, Prescott MR, Bhatasara T, Murwira M, Mangwiro AZ, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS ONE. 2020;15(1): e0227632.CrossRef Gombe MM, Cakouros BE, Ncube G, Zwangobani N, Mareke P, Mkwamba A, Prescott MR, Bhatasara T, Murwira M, Mangwiro AZ, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS ONE. 2020;15(1): e0227632.CrossRef
13.
go back to reference Bjertrup PJ, Mmema N, Dlamini V, Ciglenecki I, Mpala Q, Matse S, Kerschberger B, Wringe A. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini. BMC Public Health. 2021;21(1):727.CrossRef Bjertrup PJ, Mmema N, Dlamini V, Ciglenecki I, Mpala Q, Matse S, Kerschberger B, Wringe A. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini. BMC Public Health. 2021;21(1):727.CrossRef
14.
go back to reference Giovenco D, Gill K, Fynn L, Duyver M, O’Rourke S, van der Straten A, Morton JF, Celum CL, Bekker L-G. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence. PLoS ONE. 2021;16(3): e0248307.CrossRef Giovenco D, Gill K, Fynn L, Duyver M, O’Rourke S, van der Straten A, Morton JF, Celum CL, Bekker L-G. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence. PLoS ONE. 2021;16(3): e0248307.CrossRef
15.
go back to reference Skovdal M, Magoge-Mandizvidza P, Maswera R, Moyo M, Nyamukapa C, Thomas R, Gregson S. Stigma and confidentiality indiscretions: intersecting obstacles to the delivery of pre-exposure prophylaxis to adolescent girls and young women in East Zimbabwe. In: Remaking HIV prevention in the 21st Century. Springer; 2021: 237–248. Skovdal M, Magoge-Mandizvidza P, Maswera R, Moyo M, Nyamukapa C, Thomas R, Gregson S. Stigma and confidentiality indiscretions: intersecting obstacles to the delivery of pre-exposure prophylaxis to adolescent girls and young women in East Zimbabwe. In: Remaking HIV prevention in the 21st Century. Springer; 2021: 237–248.
16.
go back to reference Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020;23(3): e25463.CrossRef Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020;23(3): e25463.CrossRef
17.
go back to reference Skovdal M, Clausen C, Magoge-Mandizvidza P, Dzamatira F, Maswera R, Nyamwanza R, Nyamukapa C, Thomas R, Gregson S. How gender norms and ‘good girl’ notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. BMC Women’s Health (under review). Skovdal M, Clausen C, Magoge-Mandizvidza P, Dzamatira F, Maswera R, Nyamwanza R, Nyamukapa C, Thomas R, Gregson S. How gender norms and ‘good girl’ notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe. BMC Women’s Health (under review).
18.
go back to reference Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019;22(4):e25276–e25276.CrossRef Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019;22(4):e25276–e25276.CrossRef
19.
go back to reference O’Rourke S, Hartmann M, Myers L, Lawrence N, Gill K, Morton JF, Celum CL, Bekker L-G, van der Straten A. The PrEP journey: Understanding how internal drivers and external circumstances impact the PrEP trajectory of adolescent girls and young women in Cape, Town South Africa. AIDS Behav. 2021;25(7):2154–65.CrossRef O’Rourke S, Hartmann M, Myers L, Lawrence N, Gill K, Morton JF, Celum CL, Bekker L-G, van der Straten A. The PrEP journey: Understanding how internal drivers and external circumstances impact the PrEP trajectory of adolescent girls and young women in Cape, Town South Africa. AIDS Behav. 2021;25(7):2154–65.CrossRef
20.
go back to reference Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41.CrossRef Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41.CrossRef
21.
go back to reference Thomas R, Skovdal M, Galizzi M, Schaefer R, Moorhouse L, Nyamukapa C, Maswera R, Mandizvidza P, Hallett T, Gregson S. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomised trial. Trials. 2020. Thomas R, Skovdal M, Galizzi M, Schaefer R, Moorhouse L, Nyamukapa C, Maswera R, Mandizvidza P, Hallett T, Gregson S. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomised trial. Trials. 2020.
22.
go back to reference Gregson S, Mugurungi O, Eaton J, Takaruza A, Rhead R, Maswera R, Mutsvangwa J, Mayini J, Skovdal M, Schaefer R, et al. Documenting and explaining the HIV decline in east Zimbabwe: the Manicaland General Population Cohort. BMJ Open. 2017;7(10): e015898.CrossRef Gregson S, Mugurungi O, Eaton J, Takaruza A, Rhead R, Maswera R, Mutsvangwa J, Mayini J, Skovdal M, Schaefer R, et al. Documenting and explaining the HIV decline in east Zimbabwe: the Manicaland General Population Cohort. BMJ Open. 2017;7(10): e015898.CrossRef
23.
go back to reference Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5(1):80–92.CrossRef Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5(1):80–92.CrossRef
24.
go back to reference Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385–405.CrossRef Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385–405.CrossRef
25.
go back to reference Pilgrim N, Jani N, Mathur S, Kahabuka C, Saria V, Makyao N, Apicella L, Pulerwitz J. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: the role of provider biases and quality of care. PLoS ONE. 2018;13(4): e0196280.CrossRef Pilgrim N, Jani N, Mathur S, Kahabuka C, Saria V, Makyao N, Apicella L, Pulerwitz J. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: the role of provider biases and quality of care. PLoS ONE. 2018;13(4): e0196280.CrossRef
26.
go back to reference Rousseau E, Katz AW, O’Rourke S, Bekker L-G, Delany-Moretlwe S, Bukusi E, Travill D, Omollo V, Morton JF, O’Malley G. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya. PLoS ONE. 2021;16(10): e0258542.CrossRef Rousseau E, Katz AW, O’Rourke S, Bekker L-G, Delany-Moretlwe S, Bukusi E, Travill D, Omollo V, Morton JF, O’Malley G. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya. PLoS ONE. 2021;16(10): e0258542.CrossRef
27.
go back to reference Poteat T, Malik M, van der Merwe LLA, Cloete A, Adams D, Nonyane BAS, Wirtz AL. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study. The Lancet HIV. 2020;7(12):e825–34.CrossRef Poteat T, Malik M, van der Merwe LLA, Cloete A, Adams D, Nonyane BAS, Wirtz AL. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study. The Lancet HIV. 2020;7(12):e825–34.CrossRef
28.
go back to reference Schwartz K, Ferrigno B, Vining S, Gomez A, Briedenhann E, Gardiner E, Jeckonia P, Torjesen K. PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa. Sex Health. 2018;15(6):570–7.CrossRef Schwartz K, Ferrigno B, Vining S, Gomez A, Briedenhann E, Gardiner E, Jeckonia P, Torjesen K. PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa. Sex Health. 2018;15(6):570–7.CrossRef
29.
go back to reference Skovdal M, Magoge-Mandizvidza P, Maswera R, Moyo M, Nyamukapa C, Thomas R, Gregson S. Stigma and confidentiality indiscretions: intersecting obstacles to the delivery of pre-exposure prophylaxis to adolescent girls and young women in East Zimbabwe. In: Bernays S, Bourne A, Kippax S, Aggleton P, Parker R, editors. Remaking HIV prevention in the 21st century: the promise of TasP, U=U and PrEP. Cham: Springer International Publishing; 2021. p. 237–48.CrossRef Skovdal M, Magoge-Mandizvidza P, Maswera R, Moyo M, Nyamukapa C, Thomas R, Gregson S. Stigma and confidentiality indiscretions: intersecting obstacles to the delivery of pre-exposure prophylaxis to adolescent girls and young women in East Zimbabwe. In: Bernays S, Bourne A, Kippax S, Aggleton P, Parker R, editors. Remaking HIV prevention in the 21st century: the promise of TasP, U=U and PrEP. Cham: Springer International Publishing; 2021. p. 237–48.CrossRef
30.
31.
go back to reference Skovdal M. Facilitating engagement with PrEP and other HIV prevention technologies through practice-based combination prevention. J Int AIDS Soc. 2019;22(S4): e25294.CrossRef Skovdal M. Facilitating engagement with PrEP and other HIV prevention technologies through practice-based combination prevention. J Int AIDS Soc. 2019;22(S4): e25294.CrossRef
Metadata
Title
Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe
Authors
Morten Skovdal
Phyllis Magoge-Mandizvidza
Freedom Dzamatira
Rufurwokuda Maswera
Constance Nyamukapa
Ranjeeta Thomas
Owen Mugurungi
Simon Gregson
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07376-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue